Market News & Trends
Singota Solutions Collaborates With Noveome Biotherapeutics to Manufacture Promising Therapy to Treat Severe Condition in People Infected with COVID-19
Singota Solutions has been selected to collaborate with Noveome Biotherapeutics, Inc. to manufacture the ST266 investigational drug product, a biologic being evaluated in….
Proveris Scientific Announces its Laboratory Compliance With cGMP
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced it is expanding its…
Proveris Scientific Announces Contract Test Services to Support Development of SARS-CoV-2 (COVID-19) Inhaled Drug Therapies & Vaccines
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced the availability of contract test services to support….
Starton Therapeutics Files PCT & US Patent Application for Continuous Delivery of Lenalidomide & Class of Immunomodulatory Agents
Starton Therapeutics Inc. recently announced it has filed PCT (Patent Cooperation Treaty) and US Non-Provisional patent applications entitled Continuous Delivery of Lenalidomide and Other Immunomodulatory…
TG Therapeutics Announces Publication of Ublituximab Phase 2 Clinical Trial Results
TG Therapeutics, Inc. recently announced the publication of results from the multicenter Phase 2 trial evaluating ublituximab, the Company’s investigational, glycoengineered, anti-CD20 monoclonal antibody, in…
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
Catalent, Inc. recently announced the appointment of Manja Boerman, PhD, to the role of President, Cell & Gene Therapy, effective June 1, 2020. In this…
Aravive & WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies
Aravive, Inc. and WuXi Biologics recently announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody platform to develop high-affinity bispecific…
TTP Collaborates With ODx to Develop New Technology to Address Antibiotic Resistance
TTP plc recently announced it has partnered with ODx (ODx Innovations Ltd), a company committed to developing a system for assessing urinary tract infections (UTIs).…
FDA Approves FENSOLVI for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
Tolmar Pharmaceuticals, Inc. recently announced the US FDA has approved its New Drug Application for FENSOLVI (leuprolide acetate) for injectable suspension for the treatment of…
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership With CytoDyn
Ajinomoto Bio-Pharma Services recently announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late stage biotechnology company, for the supply of the investigational new drug….
Arcturus Therapeutics & Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Arcturus Therapeutics Holdings Inc. and Catalent, Inc.recently announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to….
Valneva & Pfizer Announce Collaboration to Co-Develop & Commercialize Vaccine
Valneva SE (Valneva) recently announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine candidate….
3M Drug Delivery Systems Launches as Independent Company, Kindeva Drug Delivery
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, recently announced its launch as an independent company following the acquisition by Altaris Capital Partners in a transaction valued at….
Adare Pharmaceuticals Acquires Orbis Biosciences
Adare Pharmaceuticals, Inc. recently announced it has acquired the pharmaceutical technology company, Orbis Biosciences, Inc. The acquisition of Orbis will….
Almac Group’s Comprehensive Service Offerings to Support Expedited COVID-19 Research Programs & Treatments
Almac Group is an established contract development and manufacturing organization (CDMO) providing an extensive range of integrated services across the drug development lifecycle to the…
Quotient Sciences & CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was recently announced today by Quotient Sciences, a leading…
WEBINAR - Developing an Oral Modified-Release (MR) Formulation: Challenges & Considerations for Achieving Success
Please join Quotient Sciences’ Vice President of Pharmaceutical Sciences, Dr. Andy Lewis, on May 20 at 10 AM London/11 AM Brussels or 6 PM London/1 PM New York for a live webinar on modified-release formulation…
Mitsubishi Chemical to Bolster Technology Platform Through Acquisition of American Organic & Inorganic Hybrid Chemicals
Mitsubishi Chemical Corporation recently announced its subsidiary Mitsubishi Chemical America, Inc. has entered into a definitive agreement to acquire all of the issued and….
Trio Pharmaceuticals & Ajinomoto Bio-Pharma Services Enter Development Collaboration for a Novel Antibody Therapeutic
Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services recently announced a development collaboration agreement to evaluate AJICAP, a proprietary site-specific conjugation technology offered by…
Stevanato Group Announces Product Development Collaboration With Cambridge Design Partnership on Pen-Injector Technology
Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products and Cambridge Design Partnership (CDP), a UK- and US-based leading technology and product design partner, recently….